LLY is trading at $1199.00, up 6.3% versus the comparison close of $1127.69 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 LLY extends move to 6.3% up
Eli Lilly and Company
Related News
LLY
Lilly's Next-Gen Drug Crushes Ozempic in Head-to-Head Trial — But Can It Justify a Trillion-Dollar Valuation?
LLY
🟢 Eli Lilly is trading 8% up today after raising 2026 revenue outlook
LLY
Eli Lilly's third quarter 2026 revenue of $24.4B beat estimates behind surging tirzepatide demand
LLY
🟢 Eli Lilly is trading 4.38% up in pre-market after retatrutide beats Ozempic in Phase 3 trial
LLY